Xingxiao Pill Suppressed the Progression of Non-Small Cell Lung Cancer by Targeting SREBP1/FASN–Induced Fatty Acid Biosynthesis via PI3K/AKT/mTOR Signaling Pathway
Xiangnan Zhou,1,2,* Xiuhua Hu,2,3,* Zhiying Zhang,2,* Shicheng Lin,2 Ximing Lin,2 Tian Zhou,2 Yanping Bai,1 Kaiwen Hu2 1Department of Dermatology, China-Japan Friendship Hospital, National Center for Integrated Traditional Chinese and Western Medicine, Beijing, 10...
Saved in:
Main Authors: | Zhou X, Hu X, Zhang Z, Lin S, Lin X, Zhou T, Bai Y, Hu K |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2025-07-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/xingxiao-pill-suppressed-the-progression-of-non-small-cell-lung-cancer-peer-reviewed-fulltext-article-CMAR |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Zuogui Pill Promotes Neurovascular Regeneration and Corticospinal Tract Remodeling After Ischemic Stroke
by: Wu D, et al.
Published: (2025-05-01) -
Role and Mechanisms of the mTOR Signalling Pathway in the Synthesis of Milk Components
by: RongNuo Li, et al.
Published: (2025-06-01) -
Exploring MAPK and mTOR Pathways in Feline Thyroid Tumors
by: Alexandra Monteiro, et al.
Published: (2025-06-01) -
Studying the relationship between mTOR activity and fertility hormones imbalances in polycystic ovary syndrome in Basra city
by: Asmaa moslim, et al.
Published: (2025-06-01) -
Downregulation of PRKCI inhibits osteosarcoma cell growth by inactivating the Akt/mTOR signaling pathway
by: Liujing Qu, et al.
Published: (2024-07-01)